Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Kukoamine B Mesilate in Sepsis Patients: a Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 2 Trial

NCT04803955 is registered in ClinicalTrials.gov with Tianjin Chasesun Pharmaceutical Co., LTD as lead sponsor.

NCT NCT04803955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04803955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Kukoamine B Mesilate in Sepsis Patients: a Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 2 Trial
Lead sponsor
Tianjin Chasesun Pharmaceutical Co., LTD
Phase
Phase 2
Overall status
Unknown status
Start date
May 15, 2021
Completion date
June 30, 2024
Enrollment
424 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis